{"id":"W2346236028","doi":"10.1200/jco.2015.33.15_suppl.5503","title":"Impact of trebananib plus weekly paclitaxel on overall survival (OS) in patients (pts) with recurrent ovarian cancer and ascites: Results from the phase III TRINOVA-1 study.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Ascites; Internal medicine; Clinical endpoint; Progression-free survival; Gastroenterology; Placebo; Paclitaxel; Randomized controlled trial; Toxicity; Ovarian cancer; Overall survival; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001559761,0.0006765308,0.001135773,0.0002530147,0.0001628519,0.0006092446,0.0005178388,0.0006570473,0.00175082],"category_scores_gemma":[0.001107744,0.0002672106,0.001975621,0.0003896923,0.0003985596,0.0004735527,0.0002946072,0.001688963,0.0003758852],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007953278,"about_ca_system_score_gemma":0.000677374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000942943,"about_ca_topic_score_gemma":0.002470104,"domain_scores_codex":[0.9996439,0.0001928485,0.00002536386,0.00005459004,0.00003135754,0.00005188784],"domain_scores_gemma":[0.9992087,0.0001923917,0.0002611694,0.00006578874,0.00003254628,0.000239416],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.826897,0.008751715,0.02547248,0.0009063075,0.004253015,0.000122883,0.0001557205,0.002666003,0.009549473,0.0001350604,0.002886995,0.1182034],"study_design_scores_gemma":[0.4233236,0.429958,0.1320879,0.0001829853,0.005101528,0.0005828267,0.0001136097,0.002222369,0.002193863,0.0004068271,0.003766459,0.00005995917],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934289,0.004468846,0.0001540322,0.0002475767,0.00006038202,0.0001952577,0.0006516055,0.00002649387,0.0007669736],"genre_scores_gemma":[0.9947768,0.001976971,0.0003326311,0.0003960514,0.000108438,0.0002556568,0.00141625,0.00001467707,0.0007224183],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00175082,"threshold_uncertainty_score":0.008248925,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1785075705041932,"score_gpt":0.487579332744831,"score_spread":0.3090717622406377,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}